Inactive Instrument
ARYx Therapeutics, Inc. Share Price Other OTC
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 9.03M 7.84M 7.31M 6.72M 12.71M 859M 12.85M 86.23M 33.71M 430M 33.93M 33.18M 1.42B | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 11.41M 9.9M 9.23M 8.48M 16.04M 1.08B 16.22M 109M 42.56M 542M 42.83M 41.89M 1.8B | EV / Sales 2008 |
4,019,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +47.06% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +47.06% | +4.62% | - | - | 33 | |
| +10.00% | +13.39% | +51.99% | +83.45% | 56.7B | |
| +0.80% | -7.82% | +24.61% | +60.00% | 51.97B | |
| -0.98% | +0.29% | -14.90% | -14.35% | 23.33B | |
| +0.30% | -5.71% | -9.15% | +345.82% | 21.34B | |
| +1.73% | -1.57% | +35.40% | -28.62% | 17.44B | |
| +4.29% | +1.67% | +201.24% | +344.48% | 14.77B | |
| +1.71% | +0.34% | +50.30% | +169.75% | 13.84B | |
| +4.16% | +4.75% | +462.40% | +177.20% | 12.12B | |
| +5.30% | -7.93% | +67.97% | +162.62% | 11.14B | |
| Average | +7.44% | -0.63% | +96.65% | +144.48% | 24.74B | |
| Weighted average by Cap. | +3.68% | +0.44% | +64.36% | +115.84% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.13 15.97 14.67 27.74 1.88K 28.05 188.26 73.59 937.88 74.07 72.45 3.11K | - |
| Net income | -31.22M -27.11M -25.27M -23.22M -43.91M -2.97B -44.39M -298M -116M -1.48B -117M -115M -4.92B | -33.17M -28.8M -26.85M -24.67M -46.65M -3.15B -47.16M -317M -124M -1.58B -125M -122M -5.23B |
| Net Debt | -29.9 -25.97 -24.21 -22.24 -42.06 -2.84K -42.52 -285.43 -111.58 -1.42K -112.3 -109.84 -4.71K | 2.37 2.06 1.92 1.76 3.33 225.54 3.37 22.63 8.85 112.74 8.9 8.71 373.56 |
Employees
-
